APIS
|
Active Pharmaceutical Ingredient |
Latin Name |
Molecular Formula |
Defination |
Structural Formula |
|
Omeprazole Capsules |
Omeprazole Capsulae |
C16H13N3O2S |
9-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]benzimidazol-2(12H)-one |
|
Product Specifications
|
Products |
Specification |
Vomume of vials |
Packing form |
|
Omeprazole Capsules |
Inner-house lastest version |
1# caps |
10caps/blister, 10blisters/box |



Adverse effect
1. The product is well tolerated.
2. Common adverse reactions are diarrhea, headache, nausea, abdominal pain, flatulence and constipation.
3. Occasionally, elevated serum aminotransferase (ALT, AST), rash, dizziness, lethargy, insomnia, etc.
4. These adverse reactions are usually mild and go away automatically, regardless of dose.
5. Long-term treatment has not seen serious adverse reactions, but in some cases can occur gastric mucosa cell proliferation and atrophic gastritis.



Matters need attention
When treating gastric ulcer, the possibility of ulcerative gastric cancer should be ruled out first. Treatment with this product can alleviate symptoms and delay treatment.
Liver and kidney insufficiency with caution.
This product is enteric capsule, take care not to chew. To prevent premature release of drug particles in the stomach and affect the curative effect.
This product is sensitive to light and heat, it is recommended to store below 20℃.
Hot Tags: omeprazole capsules, China omeprazole capsules manufacturers, suppliers, factory, Omeprazole Capsules, Flurocemide Injection, Vitamin B Complex For Injection, , Ceftriaxone Sodium And Sulbactam Sodium For Injection, Oxacillin Sodium For Oral Suspension









